SCHEMBL29888641

SCHEMBL29888641

COc1cc(O)c(-c2c(O)cc(OC)cc2C(C)(C)C)c(C(C)(C)C)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.67
CA2 P00918 1/20 0.67
ALDH1A1 P00352 7/20 0.50
CYP3A4 P08684 5/20 0.50
GAA P10253 2/20 0.50
ALOX15 P16050 4/20 0.47
HPGD P15428 4/20 0.47
LMNA P02545 2/20 0.47
TP53 P04637 2/20 0.47
KDM4E B2RXH2 4/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
MAPT P10636 3/20 0.44
CYP1A2 P05177 1/20 0.44
ATP2A2 P16615 1/20 0.44
ATP2A3 Q93084 1/20 0.44
GLA P06280 1/20 0.42
ELANE P08246 1/20 0.42
HSD17B10 Q99714 2/20 0.42
NR1I2 O75469 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2295824 1.00 CA1 (0.67) CA1CA2ALDH1A1CYP3A4GAA
SCHEMBL70237 0.83 CA2 (0.80) CA1CA2ALDH1A1CYP3A4GAA
SCHEMBL2286896 0.82 CA2 (0.44) CA1CA2ALDH1A1CYP3A4GAA
SCHEMBL28067778 0.81 CA1 (0.58) CA1CA2ALDH1A1GAAALOX15
SCHEMBL39130 0.80 CA2 (1.00) CA1CA2ALDH1A1CYP3A4GAA
SCHEMBL2292870 0.79 CA1 (0.41) CA1CA2ALDH1A1CYP3A4GAA
SCHEMBL2288807 0.79 CA1 (0.41) CA1CA2ALDH1A1CYP3A4GAA
Hydroquinone SCHEMBL7796131 0.78 CA2 (0.84) CA1CA2ALDH1A1CYP3A4GAA
SCHEMBL1270682 0.78 CA2 (0.84) CA1CA2ALDH1A1CYP3A4GAA
SCHEMBL2293680 0.76 ELANE (0.49) CA1CA2ALDH1A1GAAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119874491-A Improved method for synthesizing, separating and purifying 3,3' -dimethoxy-5, 5' -dimethyl-2, 2' -biphenol 重庆工商大学 2025-04-25 CN disclosed
US-20250011354-A1 Process for preparing diphosphites EVONIK OXENO GMBH & CO. KG (DE) 2025-01-09 US disclosed
EP-4484437-A1 PROCESS FOR THE PREPARATION OF DIPHOSPHITES Evonik Oxeno GmbH & Co. KG (DE) 2025-01-01 EP disclosed
CN-119192244-A Process for preparing bisphosphites 赢创奥克森诺有限责任两合公司 2024-12-27 CN disclosed
CN-114988991-B Method for preparing isomeric aldehyde by hydroformylation of olefin 中海油天津化工研究设计院有限公司 2024-02-09 CN disclosed
CN-114988991-A Method for preparing isomeric aldehyde by olefin hydroformylation 中海油天津化工研究设计院有限公司 2022-09-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250011354-A1 Process for preparing diphosphites DCPS, DCTPP1, PPIP5K2 CA1 3440/4885CA2 3489/4885ALDH1A1 3568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.